Akeso Announces the Completion of Patient Enrollment in the Phase III Clinical Trial (HARMONi-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-NSCLC

HONG KONG, Feb. 6, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or the…

SunCar Technology Group Announces Pricing of $50 Million Follow-On Public Offering of Class A Ordinary Shares

NEW YORK, Feb. 6, 2025 /PRNewswire/ — SunCar Technology Group Inc. ("SunCar")…

St. Luke's Medical Center Achieves GHA Accreditation for Medical Travel Services

PALM BEACH GARDENS, Fla., Feb. 6, 2025 /PRNewswire/ — St. Luke’s Medical Center has…

OKX Australia Reinvents How Australians Trade Crypto with Launch of Innovative Trading Bots

Crypto platform celebrates launch with ‘Bot Up Your Game’ campaign offering up…

Transforming Entertainment with AI: Vyin AI Redefines Hyper-Personalized Interactions

TAIPEI, Feb. 6, 2025 /PRNewswire/ — Vyin AI, an artificial intelligence brand…

SK hynix Acquires 'TISAX' Certification for the First Time in the Memory Industry

– Acquires TISAX certification for domestic sites, meeting the level of information…

Foretellix and MathWorks Partner on Innovative Toolchain to Accelerate Mazda's Next Generation AV Development

TOKYO and  SUNNYVALE, Calif. , Feb. 6, 2025 /PRNewswire/ — Strategic technological integration…

Argent BioPharma: A Hidden Gem traded Under $12M–Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment

PERTH, Australia, Feb. 6, 2025 /PRNewswire/ — Argent BioPharma (ASX: RGT) (OTCQB:…